Share

Heart Failure 2007

A full Press Working Area will be available. The hours are:

Saturday 9 June, 12:00 - 20:30

• Sunday 10 June, 07:30 - 19:30
• Monday 11 June, 07:30 - 19:30
• Tuesday 12 June, 07:30 - 13:00

Information on the scientific session can be accessed here:

The Heart Failure 2007 Congress is organised by the Heart Failure Association of the European Society of Cardiology. Each year more than 3,500 experts in the field gather to discuss the latest discoveries in the field. There will be 57 scientific sessions, 14 satellite sessions, 6 moderated poster sessions, 4 poster sessions and 2 "Meet the Experts" sessions. More than 1,000 abstracts were submitted and 50% were accepted.

Highlighted presentations include:

Saturday 9 June

• Room 1: Opening Ceremony
• The HFA of the ESC Honorary Lecture: The future of Biomarkers in heart failure - E. Braunwald (US)

Sunday 10 June:

• Room 2 at 08.30
• "Biomarkers are better than clinicians in diagnosing heart failure: Pro. S.D.Anker (Berlin,DE) Con. I.S.Anand (Edina, US)

• Room 3 at 16.00
• The adult human atrium – a realistic cell source for therapy" (P. Doevendans)
• The human testis – a realistic cell source for therapy (G. Hasenfuss)

Monday 11 June:

• Room 1 at 08.30
• CRP and natriuretic peptides – do they tell a different story" T.A. McDonagh (London, GB)

• Room 2 at 08.30
• Levosimendan is a first-line drug in the management of acute heart failure Pro: (F. Follath); Contra: (J. Cleland)
• BNP is an obligatory biomarker for long-term management of chronic heart failure Pro: (G. Jondeau); Contra: (J.J.V. McMurray)

• Room 1 at 11.00
• Haemodynamic monitoring: tool or toy" (G.S. Filippatos)
• ICD: a shock box does it all K.H. Kuck (Hamburg, DE)

• Room 5 at 11.00
• Depression and prognosis in heart failure: what can we learn from CAD" N. Frasure-Smith (Montreal, CA)
• Detection and treatment of depression in routine care of patients with heart failure (C.E. Angermann)

• Room 2 at 16.00
• How to diagnose diastolic function in the clinical routine C. Tschoepe (Berlin, DE)
• Therapeutic options in the treatment of diastolic dysfunction J.J.V. McMurray (Glasgow, GB)

Tuesday 12 June:

• Room 1 at 08.30
• Renal failure in the elderly patient – implications for pharmacotherapy and outcome D.J. Van Veldhuisen (Groningen, NL)
• Anaemia in the elderly – cause or consequence of heart failure" M.C. Fonseca (Oeiras, PT)

• Room 5 at 08.30
• How to manage acute decompensated heart failure in patients with adult congenital heart disease. L Swan (London, UK)

• Room 2 at 11.00
• Surgical treatment of mitral regurgitation: role in treatment of CHF. M. Enriquez-Sarano (Rochester, US)
• Interventional non-surgical MR-treatment. P. Serruys (Rotterdam, NL)

Special sessions include:

• Sunday 10 June, 11:00 - 12:30 Room 6 -Young Investigators' Award Basic science.
• Sunday 10 June, 14:00 - 15:30 Room 6 - Young Investigators' Award Clinical science.
• Monday 11 June, 11:00 - 12:30 Room 2 - Late Breaking Trials.
• Monday 11 June, 16:00 - 17:30 Room 1 - Hyde Park Corner.

Registration is open for the Heart Failure Congress 2007, being held in Hamburg, Germany from June 9-12. Registration for journalists is free.

To register, please email the Heart Failure Registration Department at HFregistration@escardio.org. Journalists should write "Press registration" in the subject line and fax a copy of your press credentials to the Heart Failure Registration Department at: +33 (0)4 92 94 76 10.

The Heart Failure Association of the ESC, a Registered Branch of the ESC, was officially launched in Munich in August 2004 and was created from the now dissolved ESC Working Group on Heart Failure.

The Mission of the HFA of the ESC is "To improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research." For more information visit http://www.escardio.org/hfa.

The European Society of Cardiology (ESC) The ESC represents more than 45,000 cardiology professionals across Europe and the Mediterranean. Its mission is "To reduce the burden of cardiovascular disease in Europe".

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.